Skip to main content
. 2021 Jul 9;11(7):e044408. doi: 10.1136/bmjopen-2020-044408

Table 2.

Medical specialists’ preferred models for delivering a genomic sequencing test in inpatient and outpatient settings (n=218)

Inpatient
n=178*
Outpatient
n=195*
n (%) 95% CI n (%) 95% CI
You initiate testing and discuss results with patients/families 4 (2.3) 0.6 to 5.6 8 (4.1) 1.8 to 7.9
You initiate testing and discuss results with patients/families, with support from a clinical genetics team as needed 43 (24.2) 18.2 to 31.1 49 (25.1) 19.2 to 31.8
You refer to a clinical genetics team to initiate testing and discuss results with patients/families 68 (38.2) 31.0 to 45.8 87 (44.6) 37.5 to 51.9
You do not see, and do not expect to see, patients who would benefit from genomic testing 33 (18.5) 13.1 to 25.0 23 (11.8) 7.6 to 17.2
Unsure at this stage 30 (16.9) 11.7 to 23.2 28 (14.4) 9.8 to 20.1

*A total of 218 respondents completed this question, indicating a preference for either the inpatient or outpatient setting or both.